Demographic and clinical comorbidities associated with the severity of infection suggest that possible variants known to influence the renin–angiotensin–aldosterone (RAAS) pathway (those that influence ACE2) may contribute to the heterogenous infection response to COVID-19. The gene discussed is ACE2; the disease is infection.